+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 20Years - 85Years
All Genders
ID06640660

Study on Visuo-spatial Abilities and Psychological Effects in Adults with Multiple Sclerosis or West Nile Virus Evaluating a New Rehabilitation Approach Using Prismatic Lenses and Cognitive Training

Led by IRCCS San Camillo, Venezia, Italy · Updated on 2024-10-15

50

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are studying visuospatial abilities and psychological outcomes in patients with Multiple Sclerosis MS and West Nile virus infection vWN. Both conditions can affect cognitive functions such as attention, memory, and executive skills. This study aims to better understand these impairments and test a new rehabilitation approach to improve visuospatial and cognitive functions. Participants will receive 10 sessions over 2 weeks of cognitive training using Mindlenses Professional, a device that combines prismatic adaptation therapy with digital serious games targeting attention, executive functions, and language. There is also a comparison group receiving standard computerized cognitive rehabilitation offered by the hospital. During the study, patients will undergo neuropsychological and psychological evaluations before and after the treatment to assess changes in cognitive performance and psychological status. The primary outcome measures cognitive changes after the 2-week intervention, while secondary outcomes assess psychological effects. The study involves randomized assignment and single masking, with a total participation period of about 2 weeks.

CONDITIONS

Brief Title

Investigating Visuo-spatial Abilities and Psychological Effects in West Nile and Multiple Sclerosis Patients with a Focus on a Possible Rehabilitation Protocol

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here